European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin |
| March 26, 2021 | March 2021 Bond Updates |
|
TOKYO and BOTHELL, Wash., March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq: SGEN) today announced that a marketing authorization application (MAA) for enfortumab vedotin was accepted by the... |
| View more at: https://www.prnewswire.com:443/news-releases/european-medicines-agency-accepts-marketing-authorization-application-for-enfortumab-vedotin-301256415.html |
| Related News |
|